244 related articles for article (PubMed ID: 31958327)
1. Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection or colonization in a Chinese teaching hospital.
Zhang D; Cui K; Wang T; Shan Y; Dong H; Feng W; Ma C; Dong Y
J Infect Dev Ctries; 2018 Aug; 12(8):642-648. PubMed ID: 31958327
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa.
Tsao LH; Hsin CY; Liu HY; Chuang HC; Chen LY; Lee YJ
J Microbiol Immunol Infect; 2018 Jun; 51(3):359-366. PubMed ID: 28988663
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Carbapenem-resistant Pseudomonas aeruginosa Infection in Children.
Li L; Huang Y; Tang Q; Zheng Y
Pediatr Infect Dis J; 2022 Aug; 41(8):642-647. PubMed ID: 35446814
[TBL] [Abstract][Full Text] [Related]
4. Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence, risk factors, and impact on outcome of infections.
Lin KY; Lauderdale TL; Wang JT; Chang SC
J Microbiol Immunol Infect; 2016 Feb; 49(1):52-9. PubMed ID: 24662016
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for mortality in patients with bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa: clinical impact of bacterial virulence and strains on outcome.
Jeong SJ; Yoon SS; Bae IK; Jeong SH; Kim JM; Lee K
Diagn Microbiol Infect Dis; 2014 Oct; 80(2):130-5. PubMed ID: 25112900
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa.
Hu Y; Qing Y; Chen J; Liu C; Lu J; Wang Q; Zhen S; Zhou H; Huang L; Zhang R
Microbiol Spectr; 2021 Dec; 9(3):e0134421. PubMed ID: 34817230
[TBL] [Abstract][Full Text] [Related]
7. Carbapenem-resistant
Huang W; Wei X; Xu G; Zhang X; Wang X
Front Public Health; 2023; 11():1088262. PubMed ID: 36844819
[TBL] [Abstract][Full Text] [Related]
8. The impact of carbapenem-resistant Pseudomonas aeruginosa on clinical and economic outcomes in a Chinese tertiary care hospital: A propensity score-matched analysis.
Chen Z; Xu Z; Wu H; Chen L; Gao S; Chen Y
Am J Infect Control; 2019 Jun; 47(6):677-682. PubMed ID: 30554879
[TBL] [Abstract][Full Text] [Related]
9. Antibiotics associated with acquisition of carbapenem-resistant Pseudomonas aeruginosa in ICUs: a multicentre nested case-case-control study.
Coppry M; Jeanne-Leroyer C; Noize P; Dumartin C; Boyer A; Bertrand X; Dubois V; Rogues AM
J Antimicrob Chemother; 2019 Feb; 74(2):503-510. PubMed ID: 30376042
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal Microbiota Disruption and Risk of Colonization With Carbapenem-resistant Pseudomonas aeruginosa in Intensive Care Unit Patients.
Pettigrew MM; Gent JF; Kong Y; Halpin AL; Pineles L; Harris AD; Johnson JK
Clin Infect Dis; 2019 Aug; 69(4):604-613. PubMed ID: 30383203
[TBL] [Abstract][Full Text] [Related]
11. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL
J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and mortality of carbapenem-resistant Pseudomonas aeruginosa bloodstream infection in haematology department: A 10-year retrospective study.
Yuan F; Li M; Wang X; Fu Y
J Glob Antimicrob Resist; 2024 Jun; 37():150-156. PubMed ID: 38615882
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
Lee CH; Su TY; Ye JJ; Hsu PC; Kuo AJ; Chia JH; Lee MH
J Microbiol Immunol Infect; 2017 Oct; 50(5):677-683. PubMed ID: 26188977
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of a hospital outbreak related to carbapenem-resistant Pseudomonas aeruginosa].
Cekin Y; Karagöz A; Kızılateş F; Cekin AH; Oztoprak Çuvalcı N; Bülbüller N; Durmaz R
Mikrobiyol Bul; 2013 Oct; 47(4):619-27. PubMed ID: 24237430
[TBL] [Abstract][Full Text] [Related]
15. Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit.
Kohlenberg A; Weitzel-Kage D; van der Linden P; Sohr D; Vögeler S; Kola A; Halle E; Rüden H; Weist K
J Hosp Infect; 2010 Apr; 74(4):350-7. PubMed ID: 20170982
[TBL] [Abstract][Full Text] [Related]
16. Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant
Zhen S; Zhao Y; Chen Z; Zhang T; Wang J; Jiang E; Zhang F; Mi Y; Zhu X; Han M; Xiao Z; Wang J; Feng S
Front Cell Infect Microbiol; 2023; 13():1156651. PubMed ID: 37415825
[TBL] [Abstract][Full Text] [Related]
17. [Risk factors for Pseudomonas aeruginosa infections, resistant to carbapenem].
Ghibu L; Miftode E; Teodor A; Bejan C; Dorobăţ CM
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1012-6. PubMed ID: 21500452
[TBL] [Abstract][Full Text] [Related]
18. [Carbapenem resistance in Pseudomonas aeruginosa isolated from urine cultures: prevalence and risk factors].
Álvarez-Otero J; Lamas-Ferreiro JL; González-González L; Rodríguez-Conde I; Fernández-Soneira MJ; Arca-Blanco A; Bermúdez-Sanjurjo JR; de la Fuente-Aguado J
Rev Esp Quimioter; 2017 Jun; 30(3):183-194. PubMed ID: 28440605
[TBL] [Abstract][Full Text] [Related]
19. [The impact of carbapenem-resistance
Wei J; Zhu QL; Sun Z; Wang C
Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):353-359. PubMed ID: 32370463
[No Abstract] [Full Text] [Related]
20. Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran.
Akhi MT; Khalili Y; Ghotaslou R; Yousefi S; Kafil HS; Naghili B; Sheikhalizadeh V
Microb Drug Resist; 2018 Mar; 24(2):126-135. PubMed ID: 28654368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
